Cardiovascular risk factors and menstrual cycle phase in pre-menopausal women

Journal of Endocrinological Investigation

Volumn 35, Issue 8, 2012, Pages 715-719

  Saxena, A R ^a   Seely, E W ^a   Goldfine, A B ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Brachial artery reactivity; CD40 ligand; Cholesterol; Insulin sensitivity; Menstrual cycle

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CD40 LIGAND; CHOLESTEROL; ESTROGEN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LUTEINIZING HORMONE; PROGESTERONE; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY REACTIVITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; FEMALE; FOLLICULAR PHASE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LUTEAL PHASE; MENSTRUAL CYCLE; NORMAL HUMAN; PREMENOPAUSE; PROSPECTIVE STUDY;

ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; FOLLICULAR PHASE; HORMONES; HUMANS; LIPIDS; LUTEAL PHASE; MENSTRUAL CYCLE; PREMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84869208329     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7977     Document Type: Article

References (41)

1. Campos H, Walsh BW, Judge H, Sacks FM. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab 1997, 82: 3955-63. (Pubitemid 27525494)
2. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998, 280: 605-13. (Pubitemid 28502636)
3. Rossouw JE, Anderson GL, Prentice RL, et al; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288: 321-33. (Pubitemid 34761611)
4. Jones DY, Judd JT, Taylor PR, Campbell WS, Nair PP. Influence of dietary fat on menstrual cycle and menses length. Hum Nutr Clin Nutr 1987, 41: 341-5. (Pubitemid 18007119)
5. Lebech AM, Kjaer A. Lipid metabolism and coagulation during the normal menstrual cycle. Horm Metab Res 1989, 21: 445-8. (Pubitemid 19206634)
6. Wunder DM, Yared M, Bersinger NA, Widmer D, Kretschmer R, Birkhäuser MH. Serum leptin and C-reactive protein levels in the physiological spontaneous menstrual cycle in reproductive age women. Eur J Endocrinol 2006, 155: 137-42. (Pubitemid 44103382)
7. Espey LL. Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod 1994, 50: 233-8. (Pubitemid 24058476)
8. Brannstrom M, Enskog A. Leukocyte networks and ovulation. J Reprod Immunol 2002, 57: 47-60. (Pubitemid 35245739)
9. Corretti MC, Anderson TJ, Benjamin EJ, et al; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002, 39: 257-65. (Pubitemid 34084631)
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412-9. (Pubitemid 15018832)
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18: 499-502.
12. Schijf CP, van der Mooren MJ, Doesburg WH, Thomas CM, Rolland R. Differences in serum lipids, lipoproteins, sex hormone binding globulin and testosterone between the follicular and the luteal phase of the menstrual cycle. Acta Endocrinol (Copenh) 1993, 129: 130-3. (Pubitemid 23254828)
13. Gill JM, Malkova D, Hardman AE. Reproducibility of an oral fat tolerance test is influenced by phase of menstrual cycle. Horm Metab Res 2005, 37: 336-41. (Pubitemid 40896219)
14. Wendler D, Michel E, Kästner P, Schmahl FW. Menstrual cycle exhibits no effect on postprandial lipemia. Horm Metab Res 1992, 24: 580-1. (Pubitemid 23000349)
15. Woods M, Schaefer EJ, Morrill A, et al. Effect of menstrual cycle phase on plasma lipids. J Clin Endocrinol Metab 1987, 65: 321-3. (Pubitemid 17103018)
16. Knopp RH, Zhu X. Multiple beneficial effects of estrogen on lipoprotein metabolism. J Clin Endocrinol Metab 1997, 82: 3952-4. (Pubitemid 27525493)
17. Knopp RH, Paramsothy P, Retzlaff BM, et al. Sex differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease. Curr Cardiol Rep 2006, 8: 452-9. (Pubitemid 44742140)
18. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996, 271: 518-20.
19. Mumford SL, Schisterman EF, Siega-Riz AM, et al. A longitudinal study of serum lipoproteins in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. J Clin Endocrinol Metab 2010, 95: E80-5.
20. Diamond MP, Simonson DC, DeFronzo RA. Menstrual cyclicity has a profound effect on glucose homeostasis. Fertil Steril 1989, 52: 204-8. (Pubitemid 19192131)
21. Valdes CT, Elkind-Hirsch KE. Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle. J Clin Endocrinol Metab 1991, 72: 642-6. (Pubitemid 21921742)
22. Yeung EH, Zhang C, Mumford SL et al. Longitudinal study of insulin resistance and sex hormones over the menstrual cycle: the BioCycle Study. J Clin Endocrinol Metab 2010, 95: 5435-42.
23. Toth EL, Suthijumroon A, Crockford PM, Ryan EA. Insulin action does not change during the menstrual cycle in normal women. J Clin Endocrinol Metab 1987, 64: 74-80. (Pubitemid 17015881)
24. Yki-Järvinen H. Insulin sensitivity during the menstrual cycle. J Clin Endocrinol Metab 1984, 59: 350-3. (Pubitemid 14053665)
25. Bingley CA, Gitau R, Lovegrove JA. Impact of menstrual cycle phase on insulin sensitivity measures and fasting lipids. Horm Metab Res 2008, 40: 901-6.
26. Blum CA, Muller B, Huber P, et al. Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women. J Clin Endocrinol Metab 2005, 90: 3230-5. (Pubitemid 41014280)
27. Jilma B, Dirnberger E, Löscher I, et al. Menstrual cycle-associated changes in blood levels of interleukin-6, alpha1 acid glycoprotein, and C-reactive protein. J Lab Clin Med 1997, 130: 69-75. (Pubitemid 27340790)
28. Capobianco G, de Muro P, Cherchi GM, et al. Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles. Arch Gynecol Obstet 2010, 282: 207-13.
29. Schönbeck U, Libby P. CD40 signaling and plaque instability. Circ Res 2001, 89: 1092-103. (Pubitemid 34627866)
30. Schönbeck U, Varo N, Libby P, Buring J, Ridker PM. Soluble CD40L and cardiovascular risk in women. Circulation 2001, 104: 2266-8. (Pubitemid 33049505)
31. Robb AO, Din JN, Mills NL, et al. The influence of the menstrual cycle, normal pregnancy and pre-eclampsia on platelet activation. Thromb Haemost 2010, 103: 372-8.
32. Souter I, Janzen C, Martinez-Maza O, et al. Serum levels of soluble vascular cell adhesion molecule-1 are decreased in women receiving oral contraceptives compared with normally menstruating women: implications in atherosclerosis. Fertil Steril 2005, 83: 1480-8. (Pubitemid 40615824)
33. Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab 2005, 90: 4542-8. (Pubitemid 41159340)
34. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257: 79-83. (Pubitemid 29299050)
35. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46: 459-69. (Pubitemid 36577787)
36. Yannakoulia M, Yiannakouris N, Blüher S, Matalas AL, Klimis-Zacas D, Mantzoros CS. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 2003, 88: 1730-6. (Pubitemid 36623396)
37. Dafopoulos K, Sourlas D, Kallitsaris A, Pournaras S, Messinis IE. Blood ghrelin, resistin, and adiponectin concentrations during the normal menstrual cycle. Fertil Steril 2009, 92: 1389-94.
38. Hall N, White C, O'Sullivan AJ. The relationship between adiponectin, progesterone, and temperature across the menstrual cycle. J Endocrinol Invest 2009, 32: 279-83.
39. Williams MR, Westerman RA, Kingwell BA, et al. Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab 2001, 86: 5389-95. (Pubitemid 33070265)
40. Bowyer L, Brown MA, Jones M. Vascular reactivity in men and women of reproductive age. Am J Obstet Gynecol 2001, 185: 88-96. (Pubitemid 32681800)
41. Adkisson EJ, Casey DP, Beck DT, Gurovich AN, Martin JS, Braith RW. Central, peripheral and resistance arterial reactivity: fluctuates during the phases of the menstrual cycle. Exp Biol Med (Maywood) 2010, 235: 111-8.